Association between time-of-day of the immune checkpoint inhibitor (ICI) infusion and disease outcomes among patients with metastatic renal cell carcinoma (mRCC).
Resource Type
Article
Authors
Dizman, Nazli ; Govindarajan, Ameish ; Zengin, Zeynep Busra ; Meza, Luis A ; Tripathi, Nishita ; Sayegh, Nicolas ; Castro, Daniela V. ; Chan, Elyse H. ; Lee, Kyle O. ; Prajapati, Sweta R. ; Feng, Matthew I. ; Loo, Vivian ; Pace, Makala ; O'brien, Shea ; Bailey, Erin B. ; Barragan-Carrillo, Regina ; Chehrazi-Raffle, Alex ; Li, Xiaochen ; Agarwal, Neeraj ; Pal, Sumanta Monty
Source
Journal of Clinical Oncology; 2/21/2023 Supplement, Vol. 41, p678-678, 1p
Subject
Language
ISSN
0732183X